carmot glp-1 Therapeutics starts phase 2 trial for CT-868, a GLP-1/GIP agonist, to treat Type 1 Diabetes Roche targets obesity market with

"We are proud to extend the Pendulum probiotic portfolio with the launch of GLP-1 Probiotic

7a,b, including replicates

DNA Cell Biol 37:10311043 Wu X, Li S, Xue P, Li Y (2017) Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving beta-catenin

This experiment more comprehensively revealed the mechanism of berberine acting on GLP-1/GLP-1R/PKA signal pathway, and also showed that islet cell probably play an important role in the treatment of T2DM, providing some ideas for the follow-up study of islet function